HealthTech Non-Invasive Monitoring Devices sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for HealthTech Non-Invasive Monitoring Devices
1.1 - About HealthTech Non-Invasive Monitoring Devices sector
Companies in this category design and manufacture non-invasive devices and connected platforms that continuously capture physiological signals outside the clinic. Offerings span medical‑grade wearables, smart home monitors, and biosensor patches that feed data to secure cloud systems. HealthTech Non-Invasive Monitoring Devices help providers and digital health programs track vitals remotely, detect deterioration earlier, and support chronic disease management with actionable, longitudinal insights.
Vendors typically offer wrist-worn wearables, adhesive ECG/PPG patches, cuffless blood pressure sensing, pulse oximetry, and continuous temperature and respiration tracking, paired with edge algorithms for artifact reduction and arrhythmia detection. Cloud RPM dashboards aggregate signals, enable clinician workflows and alerts, and integrate with EHRs via HL7/FHIR. Many provide APIs, device management, data quality monitoring, and AI-based risk scores for early intervention and triage.
Primary customers include health systems and provider groups deploying remote patient monitoring, telehealth platforms integrating continuous vitals, and health plans supporting chronic care. These solutions improve clinical visibility between visits, enable earlier escalation and reduced readmissions, increase program adherence and patient engagement, and lower the cost of managing cardiometabolic and respiratory conditions while supporting quality metrics and reimbursement for RPM services.
2. Buyers in the HealthTech Non-Invasive Monitoring Devices sector
2.1 Top strategic acquirers of HealthTech Non-Invasive Monitoring Devices companies
Dexcom
HQ: United States
Website
- Description: Provider of continuous glucose monitoring solutions for diabetes management, Dexcom develops, manufactures and distributes a range of CGM systems worldwide, operating from its San Diego headquarters with additional manufacturing sites in the United States, Malaysia and Ireland.
- Key Products:
- Dexcom G7 Continuous Glucose Monitoring System: Wearable sensors deliver real-time glucose readings
- optional receiver or smart device displays data, with over $200 receiver savings and Medicare compatibility benefits
- Dexcom Pharmacy Savings Program: Coupon-based offer giving $210 off each 30-day sensor pack and transmitter, saving users over 50% on standard cash prices at retail and Amazon pharmacies
- Dexcom Patient Assistance Program: Income-based discount initiative requiring application and documentation, providing qualified U.S. residents reduced out-of-pocket costs for Dexcom CGM products
- Stelo Glucose Sensing Solution: Non-prescription, affordable device for type 2 diabetics not on insulin, providing real-time glucose readings and insights to support healthier lifestyle decisions.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for HealthTech Non-Invasive Monitoring Devices sector
M&A buyer group 1: Remote Patient Monitoring
19 companies
View group →
Description: Companies in the Digital Health Remote Patient Monitoring Platforms category provide cloud-based systems that connect at-home patients to clinical teams through connected devices and secure data pipelines. They aggregate physiologic signals, surface actionable insights, and orchestrate care workflows, enabling earlier intervention and reimbursable remote care. Offerings typically span device management, EHR integration, patient engagement, and analytics, helping providers scale virtual care programs with measurable clinical and financial impact.
Huma
HQ: United Kingdom
- Type: N/A
- Employees: ●●●●●
- Description: Provider of AI-driven digital health solutions that include a cloud platform for rapidly building regulated health apps, remote patient monitoring, virtual wards and clinical trial tools, plus AI modules that automate documentation, triage and care workflows to optimise patient outcomes.
- Key Products:
- Huma Cloud Platform: Highly configurable, flexible, disease-agnostic cloud infrastructure offering code-free configuration, multi-device connectivity and hosting of AI/ML models with multiple regulatory clearances for rapid digital health solution deployment
- Remote Patient Monitoring Programmes: Programmes capture real-world health data, enable continuous remote monitoring and self-management, empowering proactive, preventative care while reducing hospital burden
- Companion Apps: Mobile companion applications integrate with the platform to support online or face-to-face consultations, deliver personalised insights and guide patients through their health journeys
- Risk Assessment Tools & AI Algorithms: AI-powered, including generative AI, algorithms analyse patient histories to generate personalised risk assessments, predictive insights and optimise treatment outcomes for clinicians and researchers.
🔒
🔒
🔒
View all 19 companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms in HealthTech Non-Invasive Monitoring Devices sector
3.1 - Buyout funds in the HealthTech Non-Invasive Monitoring Devices sector
2.2 - Strategic buyer groups for HealthTech Non-Invasive Monitoring Devices sector
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for HealthTech Non-Invasive Monitoring Devices companies
4.2 - Public trading comparable groups for HealthTech Non-Invasive Monitoring Devices sector
Valuation benchmark group 1: Medical Monitoring and Respiratory Device Companies
11 companies
View group →
Description: Companies in this trading comparables group manufacture and supply clinical patient monitoring and respiratory care devices used across acute and ambulatory settings. Their business models combine capital equipment placement with recurring revenue from disposables, software, and service. They are comparable given shared regulatory pathways, hospital procurement dynamics, connectivity to clinical workflows, and similar revenue mix between hardware, consumables, and digital health monitoring platforms.
ResMed
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of cloud-connectable medical devices and digital health technologies aimed at diagnosing, treating, and managing sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory disorders, thereby enhancing patient health and quality of life.
- Key Products:
- CPAP Devices: Cloud-connectable CPAP machines for sleep apnea treatment
- CPAP Masks: Comfortable and effective masks for CPAP therapy
- Respiratory Care Devices: Ventilators and bilevel devices for respiratory support
- Digital Health Solutions: Software platforms for managing respiratory conditions
- Accessories: Tubing, humidifiers, and other CPAP accessories for enhanced therapy
🔒
🔒
🔒
View all 11 companies in this group
Request Free Trial Now →
🔒
Revenue growth
Median
15.7%
2025E
16.0%
2026E
EBITDA margin
Median
28.2%
2025E
28.6%
2026E
Cash EBITDA margin
Median
27.6%
2025E
28.0%
2026E
EV/Revenue
Median
8.4x
2025E
6.8x
2026E
EV/EBITDA
Median
28.9x
2025E
24.4x
2026E
EV/Cash EBITDA
Median
29.0x
2025E
25.5x
2026E
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →